Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Tria... by Zaishang Li, Zaishang Li, Zaishang Li, Xueying Li, Wayne Lam, Yabing Cao, Hui Han, Hui Han, Hui Han, Xueqi Zhang, Xueqi Zhang, Xueqi Zhang, Jiequn Fang, Jiequn Fang, Jiequn Fang, Kefeng Xiao, Kefeng Xiao, Kefeng Xiao, Fangjian Zhou, Fangjian Zhou, Fangjian Zhou

Subjects: Get full text

PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer by Hanqun Zhang, Shisheng Tan, Chunju Fang, Qi Zhang, Xue Cao, Yuncong Liu

Subjects: Get full text

Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis by Mohammad Reza Javan, Saeed Aslani, Mohammad Reza Zamani, Javad Rostamnejad, Milad Asadi, Mahdi Farhoodi, Mohammad Hossein Nicknam

Subjects: Get full text

Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma by Fereshteh Ameli, Elham Shajareh, Maral Mokhtari, Farid Kosari

Subjects: Get full text

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance by Feng YC, Ji WL, Yue N, Huang YC, Ma XM

Subjects: “…Programmed cell death 1…”
Get full text

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer by Maureen L. Drakes, Swati Mehrotra, Monica Aldulescu, Ronald K. Potkul, Yueying Liu, Anne Grisoli, Cara Joyce, Timothy E. O’Brien, M. Sharon Stack, Patrick J. Stiff

Subjects: “…Programmed cell death-1…”
Get full text

Nivolumab-Induced Thyroid Dysfunction by Lohit Kumbar, Chitra Selvan, Y P Ganavi

Subjects: Get full text

Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension by Siqi Sheng, Siqi Sheng, Siqi Sheng, Siqi Sheng, Yixian Ma, Yixian Ma, Yixian Ma, Yixian Ma, Yue Zou, Yue Zou, Yue Zou, Yue Zou, Fangyuan Hu, Fangyuan Hu, Fangyuan Hu, Fangyuan Hu, Ling Chen, Ling Chen, Ling Chen, Ling Chen

Subjects: Get full text

Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma by Seiichi Yano, Kenji Ashida, Hiromi Nagata, Kenji Ohe, Naoko Wada, Yukina Takeichi, Yuki Hanada, Yuta Ibayashi, Lixiang Wang, Shohei Sakamoto, Ryuichi Sakamoto, Hiroshi Uchi, Motoaki Shiratsuchi, Masutaka Furue, Masatoshi Nomura, Yoshihiro Ogawa

Subjects: Get full text

Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors by Shimozaki K, Sukawa Y, Beppu N, Kurihara I, Suzuki S, Mizuno R, Funakoshi T, Ikemura S, Tsugaru K, Togasaki K, Kawasaki K, Hirata K, Hayashi H, Hamamoto Y, Takaishi H, Kanai T

Subjects: Get full text

Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression by Shubai Zhong, Yuanqin Yin

Subjects: Get full text

Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer by Kosei Hasegawa, Shunji Takahashi, Kimio Ushijima, Masao Okadome, Kan Yonemori, Harushige Yokota, Ignace Vergote, Bradley J. Monk, Krishnansu S. Tewari, Keiichi Fujiwara, Jingjin Li, Shaheda Jamil, Anne Paccaly, Kazuhiro Takehara, Tomoka Usami, Yoichi Aoki, Nao Suzuki, Yoichi Kobayashi, Yoshio Yoshida, Hidemichi Watari, Frank Seebach, Israel Lowy, Melissa Mathias, Matthew G. Fury, Ana Oaknin

Subjects: Get full text

A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model by Timothy W. Phares, Vinayaka Kotraiah, Deshapriya S. Karunarathne, Jing Huang, Cecille D. Browne, Peter Buontempo, Marc Mansour, Amy R. Noe, Michelle N. Wykes, James Pannucci, Moriya Tsuji, Gabriel M. Gutierrez

Subjects: Get full text

Programmed cell death 1 inhibitor alone or combined with chemotherapy for patients with locally advanced or metastatic urothelial carcinoma: a single-center experience by Xing Huang, Chupeng Sun, Peng Zhang, Lei Wang

Subjects: “…Programmed cell death 1…”
Get full text

Inhibition of PI3Kδ Differentially Regulates Poly I:C– and Human Metapneumovirus–Induced PD–L1 and PD–L2 Expression in Human Bronchial Epithelial Cells by Tomohiro Ogawa, Keiko Kan-o, Keiko Kan-o, Ayaka Shiota, Akitaka Fujita, Yumiko Ishii, Satoru Fukuyama, Koichiro Matsumoto

Subjects: “…programmed cell death 1 ligand 1…”
Get full text

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients by Peng Song, Dongliang Yang, Hanping Wang, Xiaoxia Cui, Xiaoyan Si, Xiaotong Zhang, Li Zhang

Subjects: Get full text

Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer by Magdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, Piotr Ciura, Claire Battin, Peter Steinberger, Katarzyna Magiera-Mularz, Grzegorz Dubin, Adam Kulesza, Adam K. Sieradzan, Marta Spodzieja, Sylwia Rodziewicz-Motowidło

Subjects: “…PD-1 - Programmed cell death 1…”
Get full text

Predictive biomarkers of response to immune checkpoint inhibitors by María Sacramento Díaz-Carrasco, Eva González-Haba, Juana Inés García-Soler, Alberto Espuny-Miró

Subjects: Get full text

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study by Stephen Lam Chan, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Becky Wing‐Yan Yuen, Hester Wing‐Sum Luk, Rashid Nok‐Shun Lui, Henry Lik‐Yuen Chan, Tony Shu‐Kam Mok, Grace Lai‐Hung Wong

Subjects: Get full text

The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome by Bo‐Hao Zheng, Jia‐Qiang Ma, Ling‐Yu Tian, Liang‐Qing Dong, Guo‐He Song, Jiao‐Men Pan, Yu‐Ming Liu, Shuai‐Xi Yang, Xiao‐Ying Wang, Xiao‐Ming Zhang, Jian Zhou, Jia Fan, Jie‐Yi Shi, Qiang Gao

Subjects: Get full text